English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduWith scheduling and shipment problems and bad weather delaying second doses of the COVID-19 vaccination, Rutgers scholar Reynold Panettieri is available to discuss the efficacy of the second dose if it is not administered exactly at the 21-day mark for…
Tag: COVID-19 Vaccine
An epidemiologist breaks down the numbers on Johnson & Johnson’s single-dose vaccine
While the Johnson & Johnson single-dose COVID-19 vaccine that has now received emergency use authorization by the U.S. Food and Drug Administration has a lower efficacy rate compared to other previously approved vaccines, an expert with The University of Texas Health Science Center at Houston (UTHealth) explains why it is still a significant step toward ending the COVID-19 pandemic.
Why COVID-19 vaccine distribution methods fall short and 3 ways to improve them
Several proposals have emerged on how to distribute the COVID-19 vaccine, but they fall short in ensuring that the vaccine is distributed fairly. A team including Binghamton University professor Nicole Hassoun suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible.
George Washington University to Participate in Sanofi COVID-19 Vaccine Trial
The George Washington University is a site for a phase 2 clinical trial for Sanofi’s adjuvanted recombinant protein-based COVID-19 vaccine candidate.
The Medical Minute: What to expect post-vaccine
For some people, anxiety over what may happen after they get the COVID-19 vaccine seems to almost outweigh the relief of getting protected. Here are some common questions and answers that should ease concerns.
Wolters Kluwer hosts panel of experts to discuss how to build COVID-19 vaccination confidence and trust in communities on February 26
The webinar “Disseminating Facts, Dispelling Myths – Building COVID Vaccine Confidence in Communities” hosted by the American Journal of Nursing (AJN) explores why many Americans are hesitant to receive a COVID-19 vaccination and looks at the primary reasons for worry, including misinformation about side effects, lack of trust, and the rapid development of the vaccines.
It’s morally wrong for rich nations to hoard COVID-19 vaccine
Rich nations should not engage in “vaccine nationalism” and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York.
Is it Safe to Get COVID-19 Vaccine while Pregnant?
Justin Brandt, an assistant professor in the Division of Maternal Fetal Medicine at Rutgers Robert Wood Johnson Medical School and director of quality and safety for the department of OB/GYN, talks about the information provided by the Centers for Disease Control and Prevention and what pregnant women should consider when deciding whether to get the COVID-19 vaccine.
“I’d Do It Again”
Rutgers medical faculty who have received their second COVID-19 vaccination discuss their side effects and give advice for those still to be vaccinated
Johnson & Johnson Seeks FDA Emergency Use Authorization for COVID-19 Vaccine
Rutgers was the second-largest Phase 3 clinical research trial site for Johnson & Johnson’s COVID-19 vaccine, which applied for emergency use authorization today from the U.S. Food and Drug Administration.
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
SEATTLE —Feb. 4, 2021 —Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.We are looking forward to the Transplantation & Cellular Therapy Meetings, to be held online Feb. 8-12. Read highlights of Fred Hutch research to be presented, including on COVID-19 and cancer and new insights on treating graft-vs.
COVID-19 Vaccine: AANEM Publishes Guidance for Patients with Neuromuscular Diseases
The AANEM Quality & Patient Safety Committee has published the paper, “Doctor – Should I get the COVID-19 vaccine? Infection and Immunization in Individuals with Neuromuscular Disorders.”
Dr. Justin Ortiz Available to Comment on COVID-19 Vaccines
Justin R. Ortiz, MD, MS Dr. Ortiz is board certified in internal medicine, pulmonary medicine, and critical care medicine. He has expertise in the clinical epidemiology and prevention of pneumonia. From 2014-2017, he was a Medical Officer at the World…
COVID-19 Vaccine Expert Available: Why You Should Sign up for Your Shot
The images are popping up on our social media feeds: pictures of friends, coworkers, and family members proudly displaying their COVID-19 vaccine card. One might have received Pfizer’s version. Another might have posted a celebratory confirmation of Moderna’s vaccine. It’s…
Pharmacies to play major role in distributing COVID-19 vaccine, sharing information
Your corner pharmacy will play a big role in delivering the COVID-19 vaccine and sharing important info with the public, according to Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York. A key…
Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine
Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
NCCN Shares New Guidance Principles for Vaccinating People with Cancer Against COVID-19
The National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.
FSU expert available to discuss new COVID-19 variants
By: Bill Wellock | Published: January 13, 2021 | 2:12 pm | SHARE: New variants of the COVID-19 virus have appeared around the world, including a more contagious variant of the COVID-19 virus that was first identified in the United Kingdom. Other variants have been identified in South Africa, Nigeria and Japan.Viruses constantly change through mutation.
COVID-19 vaccine creates incentive to improve our health
While we wait for our turn to get vaccinated against SARS-CoV-2, we could – and probably should – use the time to make sure we bring our healthiest emotional and physical selves to the treatment, a new review of previous research suggests.
Top 2021 pandemic tips for older adults (and the people who love them)
As the vaccine becomes available to older adults, and case of COVID-19 surge, a list of key tips and relevant links for older adults about getting through this winter safely and healthily.
The Medical Minute: How the body responds to the COVID-19 vaccine
Is the COVID-19 vaccine safe for people with food allergies? Two infectious disease experts offer answers and explain how the body accepts the vaccine in this week’s Penn State Health Medical Minute.
MEDIA ALERT—JAN. 5 VIRTUAL PRESS BRIEFING
Keck Medicine of USC to provide COVID-19 update on staff vaccinations; future patient and community efforts
5 Things You Must Do While You Wait for the COVID-19 Vaccine
Even as vaccinations against COVID-19 are under way, the virus continues to kill thousands of Americans every day, making it more important than ever to stay safe and be ready in case it strikes you or your family. Here’s what you need to do to prevent and prepare for the novel coronavirus.
Healthcare Heroes: 10 Months on the COVID-19 Front Lines
When Joni Stokx, RN, heard that the COVID-19 vaccine was coming, it brought her to tears. A nurse at Cedars-Sinai Marina del Rey Hospital, she’s been caring for COVID-19 patients for 10 months. While she and her co-workers wear all the recommended personal protective equipment (PPE) and take lots of precautions, getting the vaccine will help her feel safer.
Rutgers Experts Available to Discuss Moderna Coronavirus Vaccine Rollout
Rutgers medical experts are available to discuss the FDA’s approval of Moderna’s coronavirus vaccine for emergency use and its rollout. The Rutgers New Jersey Medical School is one of only two sites for the Phase 3 trial of the Moderna…
COVID-19 vaccination begins at UChicago Medicine
First UChicago Medicine employees vaccinated against SARS-CoV-2; Paves way for thousands more to be scheduled over next several weeks
Cedars-Sinai Frontline Workers Receive First Dose of COVID-19 Vaccine
The first wave of Cedars-Sinai staff members are receiving the much-anticipated COVID-19 vaccine Thursday morning, an occasion that is bringing hope and relief to those who have fought on the medical frontline for nearly a year against the deadly illness.
New Jersey Headquartered Banks Commit Over $145,000 to Support Hackensack Meridian Health’s COVID-19 Vaccination Efforts
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, is pleased to announce that more than $145,000 has already been granted by several leading New Jersey headquartered banks and affiliated foundations, including: OceanFirst Bank, Peapack-Gladstone Bank, Manasquan Bank and Valley Bank.
George Washington University Public Health/Medical Experts Available for Media Interviews on COVID-19 Vaccine
On Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19 vaccine, paving the way for approval. Researchers at the George Washington University led one of the 100 clinical sites testing…
Early Access to COVID-19 Vaccination Essential for Anesthesia Professionals, ASA Says
With the first round of COVID-19 vaccines being deployed to states across the country, the American Society of Anesthesiologists (ASA) advises that anesthesia professionals, and other frontline health care workers, be prioritized to receive early access to the COVID-19 vaccination given their high risk of exposure to the virus in operating rooms, labor and delivery suites, procedural areas, emergency rooms and critical care units.
MEDIA ALERT—VIRTUAL PRESS CONFERENCE
Join us for a virtual press conference as Keck Medicine of USC experts discuss how the health system is handling the receipt and distribution of vaccines the day before vaccinations begin.
Rutgers Expert Available to Discuss Rich Countries Hoarding Coronavirus Vaccine
Richard Marlink, director of the Rutgers Global Health Institute, is available to discuss the global health impact of coronavirus vaccine hoarding by rich countries and how such measures may derail worldwide efforts in fighting the pandemic. “Hoarding of vaccines by…
COVID-19 Crisis Communication Expert Available
In a world where conspiracy theories and political polarization abound, how does one effectively pull off double duty at battling against both the spread of COVID-19 and misinformation about it? For answers, we turned to Rebecca Rice, a UNLV Greenspun College of Urban Affairs professor who specializes in crisis communication.
George Washington University Public Health/Medical Experts Available for Media Interviews on the COVID-19 Pandemic
Public health experts predict the United States may be headed for thousands of new COVID-19 cases and deaths this winter, a surge that is already straining health care systems around the country. The George Washington University has the following experts…
The Ethics of Human Challenge Trials
A Rutgers philosopher examines the ethical questions around human challenge trials for COVID-19 vaccines
Rutgers Expert Available to Discuss COVID-19 Vaccine Distribution Priorities
Perry N. Halkitis, dean of the Rutgers School of Public Health, is available to discuss the priorities for COVID-19 vaccination distribution. “It is essential that we prioritize vaccinations for healthcare providers and nursing home residents, but they are not the…
Nearly Half of Community Health Center Patients Qualify for Phase One COVID-19 Vaccinations
Nearly half of all patients served by community health centers (CHCs) qualify for phase one COVID-19 immunizations under priority guidelines established by the Centers for Disease Control and Prevention, according to a new analysis produced by researchers at the Geiger Gibson/RCHN Community Health Foundation Research Collaborative.
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
SEATTLE – Dec. 2, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.If you’re following the American Society of Hematology’s annual meeting (virtual, Dec. 5-8), see our media tip sheet highlighting Fred Hutch presentations and activities, including those by current ASH president Dr.
Rutgers Vaccine Expert Available to Discuss Moderna’s FDA Submission
Rutgers’ principal investigator for the Moderna phase 3 coronavirus vaccine clinical trial at Rutgers New Jersey Medical School is available to discuss the drugmaker’s submission of its vaccine to the U.S. Food and Drug Administration for regulatory approval. “It is…
COVID-19 Update: Surge Preparedness, Vaccine Distribution
With the novel coronavirus spreading across the U.S. at a record pace, Cedars-Sinai has been seeing an increase in COVID-19 patients at its hospitals and through its network of physicians. But the health system’s leaders say Cedars-Sinai is prepared.
Experts Issue Recommendations for Equitable Distribution of COVID-19 Vaccine
A group of vaccine experts led by Children’s Hospital of Philadelphia (CHOP) has published recommendations to ensure equitable distribution of a COVID-19 vaccine when it becomes available. The framework, published today in Heath Affairs, focuses on five principles the authors believe would strengthen the current immunization delivery system to ensure equitable access to everyone for whom vaccination is recommended.
Rutgers Expert Available to Comment on Pfizer Announcement of Coronavirus Vaccine Efficacy
Reynold Panettieri, Vice Chancellor for Translational Medicine and Science at Rutgers University, is available to discuss the next steps in a vaccine roll-out after Pfizer’s announcement that its coronavirus vaccine was 95 percent effective and had no serious side effects.…
Rutgers Infectious Disease Expert Available to Discuss Moderna’s Coronavirus Vaccine
Rutgers’ principal investigator for the Moderna phase 3 coronavirus vaccine clinical trial at Rutgers New Jersey Medical School is available to discuss the drugmaker’s vaccine, which the company has announced is 94.5 percent effective. Moderna intends to seek an emergency…
Pfizer, Moderna news is promising, but billions are unlike to get COVID-19 vaccine for years
In just a week, both Moderna and Pfizer have announced that they have developed effective vaccines against COVID-19 — but how long will it be before everyone has access to them? According to Nicole Hassoun, professor of philosophy at Binghamton…
Rutgers Expert Available to Discuss Pfizer’s Vaccine
A Rutgers public health expert is available to discuss Pfizer’s vaccine, which has shown to be effective according to recent clinical results, and the steps we can take to increase public trust when a COVID-19 vaccine is finally approved. “The…
FSU expert available to discuss COVID-19 vaccine development
Published: November 10, 2020 | 3:47 pm | SHARE: There may be good news on the horizon regarding a COVID-19 vaccine.Pfizer and partner BioNTech reported that their trial vaccine appears to have a 90 percent efficacy rate, meaning that test subjects who received a vaccine experienced 90 percent fewer cases of symptomatic COVID-19 than those who received a placebo.
Expert available to discuss best methods for communicating about COVID-19 vaccine
On Monday, Pfizer announced early results from its coronavirus vaccine trial that showed their vaccine is more than 90 percent effective – signaling that the vaccine may be closer than ever to being distributed. Katharine Head, an associate professor of…
Preclinical data for COVID-19 vaccine candidate show effectiveness and advantages
A COVID-19 vaccine candidate that underwent extensive preclinical testing this spring and summer shows potent preclinical immune responses — including several that distinguish it from other COVID-19 vaccine approaches — according to a preprint deposited in the BioRxiv repository.
Rutgers Experts Explore Questions, Concerns Over COVID-19 Vaccine Trials
As researchers race to develop a COVID-19 vaccine, a Rutgers infectious disease expert and a Rutgers bioethicist discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials and what a successful vaccine may mean.